News Room

Leading Expert in Women’s Health Elected to Guided Therapeutics Board of Directors

Guided Therapeutics Reports First Quarter 2010 Results... Read More

Guided Therapeutics’ Cervical Scan Could Save Money, Reduce Suffering According to Results Presented at Europe’s Foremost International Congress for OB-GYN... Read More

Konica Minolta Opto, Inc. Extends Product Development Licensing Agreement with Guided Therapeutics... Read More

LightTouch in the news. WSVN News in Miami report... Click to view

Guided Therapeutics LightTouch Cervical Scan FDA Trial Indicates Improved Detection of Significant Disease over Pap in Private Office Setting

Guided Therapeutics LightTouch Cervical Scan FDA Clinical Trial Indicates Adolescent’s Risk for Cervical Disease on Par with Adult Women

Guided Therapeutics’ LightTouch Cervical Scan Detected Disease Up to Two Years Earlier Than Pap, HPV and Biopsy in FDA Pivotal Clinical Trial

Top Doctors to Present Results of FDA Clinical Trial of Guided Therapeutics’ Cervical Cancer Detection Technology at Scientific Meeting

Guided Therapeutics, Inc. Receives New Funding Commitment from Konica Minolta Opto, Inc. to Expand Cancer Detection Product Line

Guided Therapeutics Non-invasive Cervical Cancer Detection Device Trial Confirms Current Tests Miss Disease; Create High False Positive Rates

Guided Therapeutics to Introduce New Cancer Detection Technology at Medica 2009

Guided Therapeutics, Inc. Awarded $2.5 million Grant by National Cancer Institute

Guided Therapeutics, Inc. and Konica Minolta Opto, Inc. to Jointly Develop Cancer Detection Products

Guided Therapeutics, Inc. Reports Preliminary Findings from FDA Pivotal Clinical Trial ...Read More

Guided Therapeutics, Inc. Submits First Module of Premarket Approval Application for Painless Cervical Cancer Detection to FDA ...Read More

Guided Therapeutics, Inc. and Konica Minolta Extend Agreement to Expand Cancer Detection Technology ...Read More

Guided Therapeutics, Inc. Announces Completion of Subject Enrollment of FDA Pivotal Clinical Trial

Guided Therapeutics, Inc. Announces the Appointment of Former Delta Air Lines CEO Ronald W. Allen to Board of Directors

Guided Therapeutics, Inc. New Stock Ticker Symbol - GTHP

Guided Therapeutics, Inc. and Konica Minolta Look to Expand Cancer Detection Technology

New Painless Test for Cervical Cancer Could Provide Access to Better Healthcare for Women Worldwide

Pre-PMA Meetings Held with FDA on Painless Cervical Cancer Test

Painless Cancer Test May Eliminate Half of Unnecessary Cervical Biopsies

Two Clinical Studies Indicate SpectRx (Guided Therapeutics) Non-invasive Cervical Cancer Detection Device Accurately Detects Disease While Reducing False Positive Results

SpectRx, Inc. (Guided Therapeutics) Granted Patent for Non-invasive Cervical Cancer Detection Technology

SpectRx, Inc. (Guided Therapeutics) Successfully Builds and Tests First Pre-production Non-invasive Cervical Cancer Detection Device

SpectRx, Inc. (Guided Therapeutics) Granted Key Patent for Non-invasive Cervical Cancer Detection Technology

Emory and (Guided Therapeutics) SpectRx, Inc. Partner in Georgia Research Alliance Innovation Fund Project for Clinical Trials of Non-invasive Cervical Cancer Detection Device

(Guided Therapeutics) SpectRx, Inc. Selected for an Additional $1.1 Million Grant by National Cancer Institute for Non-invasive Cervical Cancer Detection Technology

(Guided Therapeutics) SpectRx, Inc. Begins Initial Phase of FDA Pivotal Clinical Trial for Non-invasive Cervical Cancer Detection Test

(Guided Therapeutics) SpectRx Completes National Cancer Institute Clinical Trial of Non-invasive Cervical Cancer Test

Published Study Shows 81% of Women Want SpectRx Non-invasive Cervical Cancer Test to Replace Pap Test